Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Experimental prostate carcinogenesis - rodent models.

T Shirai1, S Takahashi, L Cui

  • 1First Department of Pathology, Nagoya City University Medical School, 1-Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Japan. tshirai@med.nagoya-cu.ac.jp

Mutation Research
|April 18, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunohistochemically demonstrated androgen receptor expression in the rat prostate during carcinogenesis induced by 3,2'-dimethyl-4-aminobiphenyl with or without testosterone.

Urologic oncology·2011
Same author

Equivocal colonic carcinogenicity of Aloe arborescens Miller var. natalensis berger at high-dose level in a Wistar Hannover rat 2-y study.

Journal of food science·2009
Same author

Antioxidant effects of flavonoids used as food additives (purple corn color, enzymatically modified isoquercitrin, and isoquercitrin) on liver carcinogenesis in a rat medium-term bioassay.

Journal of food science·2008
Same author

Promotion potential of madder color in a medium-term multi-organ carcinogenesis bioassay model in F344 rats.

Journal of food science·2008
Same author

Thirteen-week feeding study of thaumatin (a natural proteinaceous sweetener), sterilized by electron beam irradiation, in Sprague-Dawley rats.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association·2005
Same author

Existence of a threshold for induction of aberrant crypt foci in the rat colon with low doses of 2-amino-1-methyl-6-phenolimidazo[4,5-b]pyridine.

Toxicological sciences : an official journal of the Society of Toxicology·2004

Selecting the right rodent model is crucial for prostate cancer research. Transgenic mouse models offer advantages over other methods, despite their limitations, for studying prostate carcinoma development.

Area of Science:

  • Oncology
  • Comparative Pathology
  • Animal Models

Background:

  • Rodent models are essential for studying prostate carcinoma development and potential interventions.
  • Spontaneous prostate tumor models allow observation of natural neoplasia but are time-consuming and have low tumor incidence.
  • Chemically induced models in rats often require long-term hormone administration and lack prostate specificity, complicating research.

Purpose of the Study:

  • To review and compare various rodent models for prostate carcinoma research.
  • To highlight the strengths and weaknesses of different experimental approaches.
  • To guide the selection of appropriate models for specific research objectives.

Main Methods:

  • Review of existing literature on rodent models of prostate carcinoma.

Related Experiment Videos

  • Analysis of experimental requirements, including time, tumor yield, and specificity.
  • Comparison of transgenic mouse models with spontaneous and chemically induced rat models.
  • Main Results:

    • Transgenic mouse models are valuable but have individual limitations.
    • Spontaneous models offer natural disease progression but are impractical for high-yield studies.
    • Chemically induced rat models are feasible but often lack specificity and require prolonged treatment.

    Conclusions:

    • No single rodent model is ideal for all prostate cancer research.
    • Careful selection of the most suitable model is critical for experimental success.
    • Transgenic mouse models represent a significant advancement in prostate carcinoma research.